logo

For the Inventor, By the Inventor

Banstead, United Kingdom

Yossi Cohen

USPTO Granted Patents = 11 

Average Co-Inventor Count = 11.0

ph-index = 5

Forward Citations = 67(Granted Patents)


Location History:

  • Banstead, GB (2008 - 2011)
  • Tel Aviv, IL (2011)
  • Woking, GB (2013 - 2015)

Company Filing History:

goldMedal11 out of 61 
 
Compugen Ltd. Corporation
 patents

Years Active: 2008-2015

Loading Chart...
11 patents (USPTO):Explore Patents
1. 8987191 - Bioactive peptides and methods of using same (2015-03-24),
2. 8828940 - Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands (2014-09-09),
3. 8492329 - Bioactive peptides and methods of using same (2013-07-23),
4. 8349801 - Peptide ligands for G-protein coupled receptors (2013-01-08),
5. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2011-03-15),
6. 7884180 - Peptides which bind to G protein-coupled receptors (2011-02-08),
7. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis (2010-11-29),
8. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease (2010-05-11),
9. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer (2009-06-30),
10. 7345142 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease (2008-03-18),
11. 7332569 - Brain natriuretic peptide spliced variant (2008-02-19),

Title: Yossi Cohen: Innovator in Bioactive Peptides

Introduction

Yossi Cohen is a prominent inventor based in Banstead, GB. He has made significant contributions to the field of bioactive peptides, holding a total of 11 patents. His work focuses on developing peptide ligands for G-protein coupled receptors, which are crucial for treating various disorders.

Latest Patents

Cohen's latest patents include innovative methods for utilizing bioactive peptides. One of his notable patents discloses peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation. Another patent outlines a method for treating ischemia-reperfusion injury-related disorders by administering GPCR ligands, further emphasizing his expertise in this area.

Career Highlights

Yossi Cohen is currently associated with Compugen Ltd. Corporation, where he continues to advance research in the field of bioactive peptides. His work has garnered attention for its potential applications in medical treatments, showcasing his dedication to innovation.

Collaborations

Cohen collaborates with talented individuals such as Zurit Levine and Ronen Shemesh, contributing to a dynamic research environment that fosters creativity and innovation.

Conclusion

Yossi Cohen's contributions to the field of bioactive peptides and his extensive patent portfolio highlight his role as a leading inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…